You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

triple-hit

Showing 1 - 25 of 2,231
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Double Hit Lymphoma, Triple Hit Lymphoma Trial in Hangzhou (Selinexor+RCHOP)

Recruiting
  • Double Hit Lymphoma
  • Triple Hit Lymphoma
  • Hangzhou, Zhenjiang, China
    Zhejiang Cancer Hospital
Aug 2, 2023

Multiple Myeloma (MM), DLBCL, Not Otherwise Specified, Double Hit Lymphoma Trial in Spain (IDP-121)

Recruiting
  • Multiple Myeloma (MM)
  • +5 more
  • Santander, Cantabria, Spain
  • +4 more
Jun 19, 2023

DLBCL, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Tampa, Florida
  • +1 more
Jan 12, 2022

Lymphoma, Relapsed Lymphoma, Refractory Lymphoma Trial in United States (fimepinostat, Rituximab, venetoclax)

Completed
  • Lymphoma
  • +10 more
  • Los Angeles, California
  • +10 more
May 5, 2021

Non Hodgkin Lymphoma, Lymphoma, B-Cell, High-grade B-cell Lymphoma Trial in Belgium, Netherlands (DA-EPOCH-R followed by

Active, not recruiting
  • Non Hodgkin Lymphoma
  • +4 more
  • DA-EPOCH-R followed by Nivolumab
  • Antwerpen, Belgium
  • +23 more
Mar 23, 2022

Large B-cell Lymphoma, DLBCL, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial (Epcoritamab)

Available
  • Large B-cell Lymphoma
  • +4 more
  • Epcoritamab
  • (no location specified)
Feb 16, 2023

Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,

Suspended
  • Burkitt Lymphoma
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Binocular Vision Disorder, Convergence Insufficiency, Headache Trial in United States (Neurolens spectacle lens, Placebo

Recruiting
  • Binocular Vision Disorder
  • +3 more
  • Neurolens spectacle lens
  • Placebo spectacle lens
  • Phoenix, Arizona
  • +9 more
Dec 1, 2021

Healthy, COPD Trial in Copenhagen (BFR during training, BFR during rest)

Recruiting
  • Healthy
  • COPD
  • BFR during training
  • BFR during rest
  • Copenhagen, Denmark
    August Krogh Building
Feb 15, 2023

Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
Jan 20, 2023

B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Lymphoma (B-ALL) Trial (PIT565)

Not yet recruiting
  • B-cell Non-Hodgkin Lymphoma (B-NHL)
  • B-cell Acute Lymphoblastic Lymphoma (B-ALL)
  • PIT565
  • (no location specified)
Jun 13, 2022

Predict CNS Involvement in Diffuse Large B-Cell Lymphoma:Danish

Completed
  • Diffuse Large B Cell Lymphoma
  • +2 more
    • (no location specified)
    Dec 13, 2021

    Headache Trial in Alcalá de Henares (percutaneous needle electrolysis, Dry needling, Sham needling)

    Not yet recruiting
    • Headache
    • percutaneous needle electrolysis
    • +2 more
    • Alcalá de Henares, Madrid, Spain
      Physioterapy and Pain center research
    Dec 14, 2022

    Aesthetic Trial in Montreal (Restylane line of injectable)

    Recruiting
    • Aesthetic
    • Restylane line of injectable
    • Montreal, Quebec, Canada
      Erevna Innovations Inc
    Apr 6, 2023

    Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Nanjing, Nanjin (Zanubrutinib, Lenalidomide, Rituximab)

    Recruiting
    • Non Hodgkin Lymphoma
    • Diffuse Large B Cell Lymphoma
    • Nanjing, Jiangsu, China
    • +1 more
    Mar 9, 2022

    Heparin-induced Thrombocytopenia, HIT, Platelet Activation Trial in Amiens (blood sample)

    Recruiting
    • Heparin-induced Thrombocytopenia
    • +7 more
    • blood sample
    • Amiens, France
      CHU Amiens
    Sep 12, 2023

    B-cell Lymphoma Trial in Beijing (Relmacabtagene Autoleucel, Fludarabine, Cyclophosphamide)

    Not yet recruiting
    • B-cell Lymphoma
    • Relmacabtagene Autoleucel
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Oct 19, 2022

    Helicobacter Pylori Infection Trial in Cheras (Lactobacillus reuteri DSM 17648 probiotic, Placebo)

    Completed
    • Helicobacter Pylori Infection
    • Lactobacillus reuteri DSM 17648 probiotic
    • Placebo
    • Cheras, Wilayah Persekutuan Kuala Lumpur, Malaysia
      The University of Malaysia Medical Centre
    May 26, 2022

    Heparin-induced Thrombocytopenia in Post-operative Cardiac

    Recruiting
    • Heparin-induced Thrombocytopenia
    • Post screening diagnostic test
    • Vandœuvre-lès-Nancy, Meurthe Et Moselle, France
      'CHRU Nancy
    Mar 23, 2023

    Haemodialysis Trial (Heparin)

    Not yet recruiting
    • Haemodialysis
    • (no location specified)
    Nov 3, 2023

    Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic Hodgkin Lymphoma, Recurrent

    Not yet recruiting
    • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
    • +21 more
    • Biopsy
    • +8 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 7, 2023

    Low Back Pain, Chronic Low-back Pain, Chronic Pain Trial (High intensity training, Moderate intensity training)

    Recruiting
    • Low Back Pain
    • +2 more
    • High intensity training
    • Moderate intensity training
    • Diepenbeek, Limburg, Belgium
      Hasselt University
    Oct 5, 2022

    Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation, Triple-Negative Breast Cancer Trial in Seattle (Veliparib,

    No longer available
    • Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation
    • Triple-Negative Breast Cancer
    • Seattle, Washington
      Seattle Cancer Care Allliance
    Jul 14, 2021

    DLBCL (DLBCL) Trial (Tisagenlecleucel)

    Withdrawn
    • Diffuse Large B-Cell Lymphoma (DLBCL)
    • Tisagenlecleucel
    • (no location specified)
    Feb 25, 2022

    Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia Trial (VLX-1005, Placebo)

    Not yet recruiting
    • Thrombocytopenia, Immune
    • Heparin Induced Thrombocytopenia
    • (no location specified)
    Mar 24, 2023